BVA9504239 DOCKET NO. 93-04 973 ) DATE ) ) On appeal from the decision of the Department of Veterans Affairs Regional Office in Wilmington, Delaware THE ISSUE Entitlement to service connection for chloracne as secondary to Agent Orange exposure. WITNESS AT HEARING ON APPEAL Appellant ATTORNEY FOR THE BOARD James L. March, Associate Counsel INTRODUCTION The veteran had active service form July 1969 to March 1971, including service in the Republic of Vietnam. This appeal comes to the Board of Veterans' Appeals (Board) from a June 1992 rating decision of the Department of Veterans Affairs (VA) Regional Office (RO) in Wilmington, Delaware. REMAND In June 1971, within one year of his return from Vietnam, the veteran was hospitalized with a dermatitis covering his entire body. The impression was generalized erythrodermatitis. In April 1992, a VA examination was conducted. The examiner, L.C. Chung, M.D., diagnosed chloracne of the back and face and behind the ears. The RO sent a memorandum to Dr. Chung requesting that he review the June 1971 hospital reports and provide an opinion as to whether the skin disorder present in June 1971 was chloracne. The RO received a note indicating that there was no reason to believe that the veteran's case of erythroderma was related to chloracne. The note, however, was not from Dr. Chung. In fact, it is not even clear whether the note was from a medical professional. Before the Board can properly address the issue on appeal, this matter must be clarified. In view of the foregoing, the Board concludes that further RO actions, as specified below, are necessary. Accordingly, the case is REMANDED to the RO for the following actions: 1. The RO should contact the veteran and request that he identify the names, addresses, and approximate dates of treatment for all VA and non-VA health care providers who have treated him for skin disability since his discharge from service. With any necessary authorization from the veteran, the RO should attempt to obtain copies of pertinent treatment records identified by the veteran which have not been previously secured. 2. Then, the RO should arrange for a VA dermatology examination of the veteran by an appropriate specialist, preferably Dr. Chung, to determine the current nature and extent of his skin disability. All indicated studies should be performed. It is imperative that the claims folder and a copy of this Remand be provided to the examining physician for review prior to the examination. The examiner is requested to provide an opinion, with detailed rationale, as to whether it is at least as likely as not that the skin disorder for which the veteran underwent treatment in June 1971 was chloracne or an acneform disease consistent with chloracne. 3. The RO should then undertake any other indicated development and readjudicate the issue on appeal. If the claim is not granted to the veteran's satisfaction, the veteran should be issued a supplemental statement of the case and be afforded a reasonable opportunity to reply. Thereafter, the case should be returned to the Board for further appellate consideration, if otherwise in order. In taking this action, the Board implies no conclusion as to any ultimate outcome warranted. No action is required of the veteran until he is otherwise notified by the RO. SHANE A. DURKIN Member, Board of Veterans' Appeals (CONTINUED ON NEXT PAGE) The Board of Veterans' Appeals Administrative Procedures Improvement Act, Pub. L. No. 103-271, § 6, 108 Stat. 740, ___ (1994), permits a proceeding instituted before the Board to be assigned to an individual member of the Board for a determination. This proceeding has been assigned to an individual member of the Board. Under 38 U.S.C.A. § 7252 (West 1991), only a decision of the Board of Veterans' Appeals is appealable to the United States Court of Veterans Appeals. This remand is in the nature of a preliminary order and does not constitute a decision of the Board on the merits of your appeal. 38 C.F.R. § 20.1100(b) (1994).